News | March 12, 2015

Many People with Congenital Heart Disease Living Longer

Increasing diagnoses of CHD attributed to better early detection methods

Congenital heart disease in adults is becoming more common as childhood treatments become more effective, according to a study from Penn State Hershey.

Congenital heart disease in adults is becoming more common as childhood treatments become more effective, according to a study from Penn State Hershey.

March 12, 2015 — At one time, many children born with congenital heart disease (CHD) suffered from issues that carried fatal prognoses. Thanks to technological advancements in the past 30 to 40 years, Elizabeth Adams, M.D., of Penn State Hershey Children's Heart Group, can predict that a child born today has a 90 percent chance of living to adulthood, even with severe CHD.

"Most children with CHD are now living to adulthood and historically that has not been the case," she said.

The Adult Congenital Heart Association (ACHA) now reports that there are an estimated 2 million adults living with CHD in the United States, meaning that, for the first time ever, there are more adults than children with CHD.

Affecting about 1 percent of the population, CHD is a genetic condition and is present from birth.

"Most of what we're talking about are structural problems with the way the heart is formed – hearts that are missing chambers, hearts that have narrow or leaky valves, or structures that are not in the right place," Adams said.

CHD is usually detected prenatally via ultrasound during pregnancy followed by a cardiac ultrasound to confirm and identify a problem. Occasionally children are not diagnosed until after birth and most of those cases are identified within the first year of life. In some less serious cases, patients are not diagnosed until much later in life.

Early detection is possible today due to sophisticated ultrasound capabilities that are now commonly used and allow doctors to find the majority of the cases prenatally.

Less invasive procedures have also been developed that can spare patients open heart surgery.

"For example, if a baby is born today with a narrow pulmonary valve, that child will probably not need surgery," Adams said.

The child would undergo a cardiac catheter procedure where a balloon is inserted into the valve to open it without an operation. In some cases, adult valve replacement or repairing small holes can be done via catheter as well.

"Instead of a week in the hospital, it's one night plus a week of recovery time instead of a couple of months," Adams said.

The incidence of congenital heart disease is increasing slightly, probably related to better detection, and in some cases, genetic transmission of cases from parent to child.

Researchers are currently trying to understand the ways in which congenital heart defects are transmitted and why some are more likely to be passed on to offspring than others.

Watch the VIDEO "Addressing Adult Congenital Heart Referrals," a discussion with Ami Bhatt, M.D., director of the adult congenital heart program and outpatient cardiology, Massachusetts General Hospital, at the 2018 American College of Cardiology (ACC) meeting.

For more information: www.pennstatehershey.org

Related Content

Feature | Cath Lab | September 14, 2021 | By Aaron Detate and Lars Thording
In the electrophysiology (EP) lab, hundreds
An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

News | Cath Lab | July 22, 2021
July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of
ast End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company's SafeCross Transseptal Radiofrequency (RF) Puncture and Steerable Balloon Introducer System. The 3-in-1 system, which includes a steerable introducer sheath with an ultra-visible positioning balloon and radiofrequency (RF) puncture dilator, aims to provide a predictable and safe solution for electrophysiology (EP) and structural heart interventions requiring left atrial access.
News | Cath Lab | July 14, 2021
July 13, 2021 — East End Medical announced it received U.S.
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone. #SCAI21 #SCAI2021 Creating a card0-renal program.

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone.

Feature | Cath Lab | May 14, 2021 | By Dave Fornell, Editor
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal fun
Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting proc

Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.

News | Cath Lab | May 12, 2021
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has
SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI heart attack. #SCAI21 #SCAI2021

SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI.

Feature | Cath Lab | May 06, 2021 | By Dave Fornell, Editor
April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria, raising questions about its application in real-world practice. #SCAI2021 Getty Images

Getty Images

News | Cath Lab | May 03, 2021
May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for sta
New study demonstrates depression, HIV, mental health, obesity, alcohol and drug abuse are risk factors on most common type of heart disease in young black patients. Photo by Dave Fornell
News | Cath Lab | April 29, 2021
April 29, 2021 – A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American
There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 

There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 

News | Cath Lab | April 28, 2021
April 28, 2021 – Results from a retrospective observational study, presented today at...